The effects of homocysteine-related compounds on cardiac contractility, coronary flow, and oxidative stress markers in isolated rat heart

Molecular and Cellular Biochemistry

Volumn 370, Issue 1-2, 2012, Pages 59-67

  Zivkovic, Vladimir ^a   Jakovljevic, Vladimir ^a   Djordjevic, Dusica ^a   Vuletic, Milena ^a   Barudzic, Nevena ^a   Djuric, Dragan ^b  

^a UNIVERSITY OF KRAGUJEVAC   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Cardiac contractility; Coronary flow; Homocysteine; Isolated rat heart; Oxidative stress

Indexed keywords

HOMOCYSTEINE; HOMOCYSTEINE THIOLACTONE; HYDROGEN PEROXIDE; NITRITE; SUPEROXIDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR PARAMETERS; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DIASTOLIC LEFT VENTRICULAR PRESSURE; FLOW MEASUREMENT; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE CONTRACTILITY; LIPID PEROXIDATION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; OXIDATIVE STRESS; RAT; SPECTROPHOTOMETRY; SYSTOLIC LEFT VENTRICULAR PRESSURE;

ANIMALS; BIOLOGICAL MARKERS; CORONARY CIRCULATION; HEART; HOMOCYSTEINE; MALE; MYOCARDIAL CONTRACTION; OXIDATIVE STRESS; RATS; RATS, WISTAR;

RATTUS;

EID: 84867334140     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-012-1398-4     Document Type: Article

References (59)

1. Selhub J (1999) Homocysteine metabolism. Annu Rev Nutr 19:217-246
2. Champe PC, Harvey RA (2008) Biochemistry. Lippincott's Illustrated Reviews 4th ed. Lippincott Williams and Wilkins
3. Jakubowski H (2008) The pathophysiological hypothesis of homocysteine thiolactone-mediated vascular disease. J Physiol Pharmacol 59:155-167
4. Jakubowski H (1997) Metabolism of homocysteine thiolactone in human cell cultures. Possible mechanism for pathological consequences of elevated homocysteine levels. J Biol Chem 272:1935-1942
5. 2+-ATPases in rats subjected to acute homocysteine and homocysteine thiolactone administration. Mol Cell Biochem 327:39-45
6. Refsum A, Ueland PM (1998) Homocysteine and cardiovascular disease. Annu Rev Medicine 49:31-62
7. Allen RH, Stabler SP, Savage DG, Lindenbaum J (1993) Metabolic abnormalities in cobalamin (vitamin B12) and folate deficiency. FASEB J 7:1344-1353
8. Kaplan ED (2003) Association between homocyst(e)ine levels and risk of vascular events. Drugs Today (Barc) 39:175-192
9. The Homocysteine Studies Collaboration (2002) Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA 288:2015-2022
10. Ford ES, Smith SJ, Stroup DF, Steinberg KK, Mueller PW, Thacker SB (2002) Homocyst(e)ine and cardiovascular disease: a systematic review of the evidence with special emphasis on case-control studies and nested case-control studies. Int J Epidemiol 31:59-70
11. Rieth A, Dill T, Deetjen A, Djuric D, Mitrovic V (2006) Effects of homocysteine-lowering therapy on endothelial function, carotid wall thickness and myocardial perfusion. Acta Fac Med Naiss 23:179-184
12. Mitrovic V, Djuric D, Petkovic D, Hamm C (2002) Evaluation of total plasma homocysteine in patients with angiographically defined coronary atherosclerosis: possible impact on therapy and prognosis. Perfusion 15:10-19
13. Tawakol A, Forgione MA, Stuehlinger M, Alpert NM, Cooke JP, Loscalzo J, Fischman AJ, Creager MA, Gewirtz H (2002) Homocysteine impairs coronary microvascular dilator function in humans. J Am Coll Cardiol 40:1051-1058
14. Wang S, Wright G, Harrah J, Touchon R, McCumbee W, Geng W, Fultz MN, Abdul-Jalil MN, Wright GL (2000) Short-term exposure to homocysteine depresses rat aortic contractility by an endothelium-dependent mechanism. Can J Physiol Pharmacol 78:500-506
15. Vignini A, Nanetti L, Bacchetti T, Ferretti G, Curatola G, Mazzanti L (2004) Modification induced by homocysteine and low-density lipoprotein on human aortic endothelial cells: an in vitro study. J Clin Endocrinol Metab 89:4558-4561
16. Su SJ, Huang LW, Pai LS, Liu HW, Chang KL (2005) Homocysteine at pathophysiologic concentrations activates human monocyte and induces cytokine expression and inhibits macrophage migration inhibitory factor expression. Nutrition 21:994-1002
17. Demuth K, Atger V, Borderie D, Benoit MO, Sauvaget D, Lotersztajn S, Moatti N (1999) Homocysteine decreases endothelin-1 production by cultured human endothelial cells. Eur J Biochem 263:367-376
18. Brown JC, Rosenquist TH, Monaghan DT (1998) ERK2 activation by homocysteine in vascular smooth muscle cells. Biochem Biophys Res Commun 251:669-676
19. Tyagi SC, Smiley LM, Mujumdar VS (1999) Homocyst(e)ine impairs endocardial endothelial function. Can J Physiol Pharmacol 77:950-957
20. Miller A, Mujumdar V, Palmer L, Bower JD, Tyagi SC (2001) Reversal of endocardial endothelial dysfunction by folic acid in homocysteinemic hypertensive rats. Am J Hypertension 15:157-163
21. Joseph J, Joseph L, Shekhawat NS, Devi S, Wang J, Melchert RB, Hauer-Jensen M, Kennedy RH (2003) Hyperhomocysteinemia leads to pathological ventricular hypertrophy in normotensive rats. Am J Physiol Heart Circ Physiol 285:H679-H686
22. Chambers JC, Mc Gregor A, Jean-Marie J, Obeid OA, Kooner JS (1999) Demonstracion of rapid onest vascular endothelial dysfunction after hyperhomocysteinemia. Circulation 99:1156-1160
23. Tyagi N, Moshal KS, Oveckin AV, Rodriguez W, Steed M, Henderson B, Roberts AM, Joshua IG, Tyagi SC (2005) Mitochondrial mechanism of oxidative stress and systemic hypertension in hyperhomocysteinemia. J Cell Biochem 96:665-671
24. Parodi O, De Chiara B, Baldassarre D, Parolini M, Caruso R, Pustina L, Parodi G, Campolo J, Sedda V, Baudo F, Sirtori C (2007) Plasma cysteine and glutathione are independent markers of postmethionine load endothelial dysfunction. Clin Biochem 40:188-193
25. Hofmann MA, Lalla E, Lu Y, Gleason MR, Wolf BM, Tanji N, Ferran LJ Jr, Kohl B, Rao V, Kisiel W, Stern DM, Schmidt AM (2001) Hyperhomocysteinaemia enhances vascular inflammation and accelerates atherosclerosis in a murine model. J Clin Invest 107:675-683
26. Bellamy MF, McDowell IF (1997) Putative mechanisms for vascular damage by homocysteine. J Inherit Metab Dis 20:307-315
27. Lentz SR, Erger RA, Dayal S, Maeda N, Malinow MR, Heistad DD, Faraci FM (2000) Folate dependence of hyperhomocysteinaemia and vascular dysfunction in cystathionine beta-synthase-deficient mice. Am J Physiol Heart Circ Physiol 279:H970-H975
28. Namekata K, Enokido Y, Ishii I, Nagai Y, Harada T, Kimura H (2004) Abnormal lipid metabolism in cystathionine beta-synthasedeficient mice, an animal model for hyperhomocysteinaemia. J Biol Chem 279:52961-52969
29. Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351-358
30. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR (1982) Analysis of nitrate, nitrite and [15 N] nitrate in biological fluids. Anal Biochem 126:131-138
31. Auclair C, Voisin E (1985) Nitroblue tetrazolium reduction. In: Greenvvald RA (ed) Handbook of methods for oxygen radical research. CRC Press Une, Boca Raton, pp 123-132
32. Pick E, Keisari Y (1980) A simple colorimetric method for the measurment of hydrogen peroxide produced by cells in culture. J Immunol Methods 38:161-170
33. Moshal KS, Kumar M, Tyagi N, Mishra PK, Metreveli N, Rodriguez WE, Tyagi SC (2009) Restoration of contractility in hyperhomocysteinemia by cardiac-specific deletion of NMDA-R1. Am J Physiol Heart Circ Physiol 296:H887-H892
34. Moshal KS, Tipparaju SM, Vacek TP, Kumar M, Singh M, Frank IE, Patibandala PK, Tyagi N, Rai J, Metreveli N, Rodriguez WE, Tseng MT, Tyagi SC (2008) Mitochondrial matrix metalloproteinase activation decreases myocyte contractility in hyperhomocysteinemia. Am J Physiol Heart Circ Physiol 295:H890-H897
35. Chen FY, Guo YH, Gao W et al (2006) Effects of hyperhomocysteinemia on cardiac remodeling in rats. J Peck Univ (Health Sci) 2:179-183
36. Joseph J, Washington A, Joseph L et al (2002) Hyperhomocysteinemia leads to adverse cardiac remodeling in hypertensive rats. Am J Physiol Heart Circ Physiol 283:H2567-H2574
37. Miller A, Mujumdar V, Palmer L, Bower JD, Tyagi SC (2002) Reversal of endocardial endothelial dysfunction by folic acid in homocysteinemic hypertensive rats. Am J Hypertens 15:157-163
38. Sood HS, Cox MJ, Tyagi SC (2002) Generation of nitrotyrosine precedes the activation of matrix metalloproteinase in left ventricle of hyperhomocystenemia rats. Antioxid Redox Signal 4(5):799-804
39. Zhang X, Li H, Jin H, Ebin Z, Brodsky S, Goligorsky MS (2000) Effects of homocysteine on endothelial nitric oxide production. Am J Physiol Renal Physiol 279:F671-F678
40. Upchurch GR Jr, Welch GN, Fabian AJ, Freedman JE, Johnson JL, Keaney JF Jr, Loscalzo J (1997) Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase. J Biol Chem 272:17012-17017
41. Stamler JS, Osborne JA, Jaraki O, Rabbani LE, Mullins M, Singel D, Loscalzo J (1993) Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J Clin Invest 91:308-318
42. Lentz SR, Sobey CG, Piegors DJ, Bhopatkar MY, Faraci FM, Malinow RM, Heistad DD (1996) Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia. J Clin Invest 98:24-29
43. Lentz SR (1997) Consequences of hyperhomocyst(e)inemia on vascular function in atherosclerotic monkeys. Arterioscler Thromb Vasc Biol 17:2930-2934
44. Maqueda MA, El Bekay R, MonteseirIn J, Alba G, Chacón P, Vega A, Santa MarIa C, Tejedo JR, Nieto JM, Bedoya FJ, Pintado E, Sobrino F (2004) Homocysteine enhances superoxide anion release and NADPH oxidase assembly by human neutrophils. Effects on MAPK activation and neutrophil migration. Atherosclerosis 172:229-238
45. Heinecke JW (1988) Superoxide-mediated oxidation of low density lipoprotein by thiols. In: Cerruti PA, Fridovich I, McCord JM, Liss AR (eds) Oxy-radicals in molecular biology and pathology. Academic Press, New York, pp 443-457
46. Harker LA, Slichter SJ, Scott CR, Ross R, Homocysteinemia (1974) Vascular injury and arterial thrombosis. N Engl J Med 291:243-537
47. Aparna P, Betigeri AM, Pasupatathi P (2010) Homocysteine and oxidative stress markers and inflammation in patients with coronary artery disease. Int J Biol Med Res 1:125-129
48. Cavalca V, Cighnetti G, Bamonti F, Loadi A, Bortone L, Novembrino C, De Franceschi M, Belardinelli R, Guazzi MD (2001) Oxidative stress in coronary artery disease. Clin Chem 47:887-892
49. Ventura P, Vanhaecke J, Janssens S, Van de Werf F, Collen D (1998) Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary sindromes and stabile coronary artery disease. Circulation 98:1487-1494
50. Huang RFS, Huang SM, Lin BS, Wei JS, Liu TZ (2001) Homocysteine thiolactone induces apoptotic DNA damage mediated by increased intracellular hydrogen peroxide and caspase 3 activation in HL-60 cells. Life Sci 68:2799-2811
51. Zappacosta B, Mordente A, Persichilli S, Minucci A, Carlino P, Martorana GE, Giardina B, de Sole P (2001) Is homocysteine a prooxidan? Free Radical Res 35:499-505
52. Chambers JC, Kooner JS (2001) Homocysteine-an innocent bystander in vascular disease? Eur Heart J 22:717-719
53. Djuric D, Vusanovic A, Jakovljevic V (2007) The effects of folic acid and nitric oxide synthase inhibition on coronary flow and oxidative stress markers in isolated rat heart. Mol Cell Biochem 300:177-183
54. De Groote MA, Testerman T, Xu Y, Stauffer G, Fang FC (1996) Homocysteine antagonism of nitric oxide-related cytostasis in Salmonella typhimurium. Science 272:414-417
55. da Cunha AA, Scherer E, da Cunha MJ, Schmitz F, Machado FR, Lima DD, Delwing D, Wyse AT (2012) Acute hyperhomocysteinemia alters the coagulation system and oxidative status in the blood of rats. Mol Cell Biochem 360:205-214
56. Kennedey RH, Owings R, Shekhawat N, Joseph J (2004) Acute negative inotropic effects of homocysteine are mediated via the endothelium. Am J Physiol Heart Circ Physiol 287:H812-H817
57. Kennedy RH, Owings R, Joseph J, Melchert RB, Hauer-Jensen M, Boerma M (2006) Acute dilatory and negative inotropic effects of homocysteine are inhibited by an adenosine blocker. Clin Exp Pharmacol Physiol 33:340-344
58. Sprince H, Parker CM, Josephs JA Jr (1969) Homocysteine-induced convulsions in the rat: protection by homoserine, serine, betaine, glycine and glycose. Agents Actions 1:9-13
59. Sipkens JA, Krijnen PAJ, Meischl C et al (2007) Homocysteine affects cardiomyocyte viability: concentration-dependent effects on reversible flip-flop, apoptosis and necrosis. Apoptosis 12:1407-1418